Barriers, facilitators, and solutions to familial hypercholesterolemia treatment.

ABSTRACT:

Background

Familial hypercholesterolemia (FH) is an inherited lipid disorder that confers high risk for premature cardiovascular disease but remains undertreated. Causes are multifactorial and multilevel, ranging from underprescribing (at the clinician-level) to medication nonadherence (at the patient-level). We evaluated patient and clinician stakeholder barriers and facilitators for treatment of FH to explore possible solutions to the problem.

Methods and results

Semi-structured interviews and focus groups guided by the Practical, Robust, Implementation and Sustainability Model (PRISM), were conducted with 33 patients and 17 clinician stakeholders across three healthcare systems. A total of14 patients and 9 clinician stakeholders participated in on-site focus groups and th

SUBMITTER: Jones LK 

PROVIDER: S-EPMC7757879 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature